BUPROPION HYDROCHLORIDE
- Product NDC
- 50090-5163
- 11-digit product format
- 500905163
- Labeler code
- 50090
- Product ID
- 50090-5163_6f3ebf11-0131-4add-860d-3c3fe243d5ee
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- BUPROPION HYDROCHLORIDE
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA210497
- Marketing category
- ANDA
- Marketing start
- 2018-11-08
- Substance
- BUPROPION HYDROCHLORIDE
- Active strength
- 150 mg/1
- Pharmacologic classes
- Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- BUPROPION HYDROCHLORIDE
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| BUPROPION HYDROCHLORIDE | 150 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | ZG7E5POY8O |
| Rxcui | 993541 |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50090-5163-0 | 50090516300 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-5163-0) | 2020-09-23 | 0000-00-00 | No | No | Current |
| 50090-5163-1 | 50090516301 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-5163-1) | 2020-09-23 | 0000-00-00 | No | No | Current |
| 50090-5163-2 | 50090516302 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-5163-2) | 2020-09-23 | 0000-00-00 | No | No | Current |